StemGen, Inc.
SGNI · OTC
6/30/2021 | 6/30/2020 | 6/30/2019 | 6/30/2018 | |
|---|---|---|---|---|
| Revenue | $39 | $19 | $22 | $0 |
| % Growth | 101.6% | -12.3% | – | – |
| Cost of Goods Sold | $30 | $9 | $9 | $0 |
| Gross Profit | $9 | $11 | $14 | $0 |
| % Margin | 21.9% | 55.7% | 61.4% | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $140 | $58 | $197 | $32 |
| SG&A Expenses | $140 | $58 | $197 | $32 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $112 | $19 | $60 | $0 |
| Operating Expenses | $252 | $78 | $257 | $32 |
| Operating Income | -$244 | -$67 | -$243 | -$32 |
| % Margin | -625.6% | -346.6% | -1,101.6% | – |
| Other Income/Exp. Net | -$189 | -$164 | -$182 | $38 |
| Pre-Tax Income | -$433 | -$231 | -$426 | $6 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$433 | -$231 | -$426 | $6 |
| % Margin | -1,110.3% | -1,192.6% | -1,931.3% | – |
| EPS | -0.01 | -0.008 | -0.02 | 0 |
| % Growth | -15.9% | 59% | -5,100% | – |
| EPS Diluted | -0.01 | -0.008 | -0.02 | 0 |
| Weighted Avg Shares Out | 45,600 | 45,428 | 24,447 | 14,084 |
| Weighted Avg Shares Out Dil | 45,600 | 45,428 | 24,447 | 14,084 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $141 | $141 | $57 | $92 |
| Depreciation & Amortization | $112 | $19 | $60 | $130 |
| EBITDA | -$180 | -$71 | -$308 | $98 |
| % Margin | -461.2% | -364.9% | -1,396.3% | – |